Improving Clinical Practice Guidelines for Antenatal Corticosteroids: Incorporating a Decision Support Tool to Tackle the Uncertain Balance of Harms and Benefits
试验速览
- 阶段
- 不适用
- 入组人数
- 460
- 试验地点
- 4
- 主要终点
- The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
研究概览
简要总结
The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Age 18 year or older.
- •Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
- •Speaks English.
- •Agrees to participate in the questionnaire during their first week post-partum.
- •Delivered at one of the six participating obstetrical hospitals.
排除标准
- 未提供
结局指标
主要结局
The change in frequency of clinical counselling about late preterm antenatal corticosteroids.
时间窗: up to 8 months following implementation of the intervention.
The difference in the proportion of patients who delivered a neonate at 34+0 to 36+6 weeks' gestation who report having had a discussion about antenatal corticosteroids with their care provider pre-intervention versus post-intervention.
次要结局
- The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.(up to 8 months following implementation of the intervention.)
研究者
Jessica Liauw
Clinical Assistant Professor
University of British Columbia
